Accelagen is a fast growing Gene-to-Protein company. Accelagen’s gene-to-protein platform integrates the latest technologies of Baculovirus Expression Vector System (BEVS), E. coli expression, mammalian expression, Wave Bioreactors, Cell Factory, and AKTA chromatography systems, providing superior protein quality and accelerating the processes from gene to protein.
Looking for a particular Accelagen employee's phone or email?
The Accelagen annual revenue was $2 million in 2026.
Chun Luo is the President and CEO of Accelagen.
4 people are employed at Accelagen.
Accelagen is based in San Diego, California.
The NAICS codes for Accelagen are [541714, 54171, 5417, 54, 541].
The SIC codes for Accelagen are [87, 873].